Vol 14, No 3 (2020)
Letter to the Editor
Published online: 2020-08-12

open access

Page views 742
Article views/downloads 334
Get Citation

Connect on Social Media

Connect on Social Media

Quality of dying and modification of implantable cardioverter-defibrillator activity

Gabriela Picco1
Palliat Med Pract 2020;14(3):227-228.

Abstract

Article available in PDF format

View PDF Download PDF file

References

  1. Niemiec A, Siejak W, Niemiec M, et al. An analysis of medical records of patients diagnosed with cardiomyopathy and provided with inpatient palliative care. Palliative Medicine in Practice. 2020; 1(1): 7–11.
  2. Goldstein NE, Lampert R, Bradley E, et al. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004; 141(11): 835–838.
  3. Ladwig KH, Ischinger NF, Ronel J, et al. [Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis]. Herzschrittmacherther Elektrophysiol. 2011; 22(3): 151–156.
  4. Picco G, Erquiaga I, Escalada H, et al. Desactivar el desfibrilador automático implantable al final de la vida: la importancia de una comunicación proactiva. Medicina Paliativa. 2016; 23(4): 212–213.



Palliative Medicine in Practice